Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An Investigation of the Effects of Tiagabine on GABA using Magnetic Resonance Spectroscopy.

Next Previous
Search
Trial Profile

An Investigation of the Effects of Tiagabine on GABA using Magnetic Resonance Spectroscopy.

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 16 Jun 2016

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Tiagabine (Primary)
  • Indications Anxiety; Epilepsy
  • Focus Pharmacodynamics

    • Most Recent Events

    • 15 Aug 2012 Accrual to date is 116% according to United Kingdom Clinical Research Network.
    • 25 Jul 2011 Status changed from recruiting to completed as reported by UKCRN.
    • 22 Jul 2011 United Kingdom Clinical Research Network reports accrual date changed from 66% to 166%.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top